Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism.

Annals of medicine - 1 Apr 2010

Ruchat Stephanie-May, Vohl Marie-Claude, Weisnagel S John, Rankinen Tuomo, Bouchard Claude, Pérusse Louis

Abstract excerpt

BACKGROUND: Although several candidate gene polymorphisms (SNPs) have been associated with increased risk of type 2 diabetes mellitus (T2DM), relatively few studies have assessed the ability of T2DM candidate genes to assess the risk of impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and T2DM beyond the information provided by clinical risk factors. OBJECTIVE: To test whether the inclusion of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Mass Index
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Predictive Value of Tests

Share to Risk Assessment

Share to Risk Factors

Share to ROC Curve

Share to Young Adult

Source

Identifiers

PMID: 20384434
DOI: 10.3109/07853890903559716

Genes

ADIPOQ

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism.PMID 20384434Read ↗

Predicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: a systematic review.Semantic proximity Read ↗

Validation of type 2 diabetes risk variants identified by genome-wide association studies in Han Chinese population: a replication study and meta-analysis.Semantic proximity Read ↗

Genetic markers of type 2 diabetes: Progress in genome-wide association studies and clinical application for risk prediction.Semantic proximity Read ↗

Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population.Semantic proximity Read ↗

Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study.Semantic proximity Read ↗

Allele summation of diabetes risk genes predicts impaired glucose tolerance in female and obese individuals.Semantic proximity Read ↗

Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies.Semantic proximity Read ↗

Clinical risk factors, DNA variants, and the development of type 2 diabetes.Semantic proximity Read ↗

Genome-wide association study and polygenic score assessment of insulin resistance.Semantic proximity Read ↗

Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies.Semantic proximity Read ↗

Is genetic testing useful to predict type 2 diabetes?Semantic proximity Read ↗

The value of genetic information for diabetes risk prediction - differences according to sex, age, family history and obesity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.